Bank of New York Mellon’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$15.6M Buy
719,747
+9,822
+1% +$213K ﹤0.01% 1648
2025
Q1
$17.2M Sell
709,925
-13,620
-2% -$330K ﹤0.01% 1575
2024
Q4
$15.1M Buy
723,545
+9,194
+1% +$192K ﹤0.01% 1715
2024
Q3
$14.2M Sell
714,351
-120,064
-14% -$2.39M ﹤0.01% 1751
2024
Q2
$12.9M Buy
834,415
+16,960
+2% +$263K ﹤0.01% 1827
2024
Q1
$13M Buy
817,455
+27,834
+4% +$444K ﹤0.01% 1826
2023
Q4
$13.3M Sell
789,621
-545
-0.1% -$9.16K ﹤0.01% 1822
2023
Q3
$9.24M Sell
790,166
-10,660
-1% -$125K ﹤0.01% 1989
2023
Q2
$10.8M Sell
800,826
-18,172
-2% -$244K ﹤0.01% 1917
2023
Q1
$13.6M Sell
818,998
-44,527
-5% -$738K ﹤0.01% 1760
2022
Q4
$16.1M Sell
863,525
-52,871
-6% -$983K ﹤0.01% 1649
2022
Q3
$11.8M Buy
916,396
+415,630
+83% +$5.33M ﹤0.01% 1809
2022
Q2
$3.51M Sell
500,766
-68,776
-12% -$482K ﹤0.01% 2513
2022
Q1
$4.72M Buy
569,542
+81,325
+17% +$674K ﹤0.01% 2455
2021
Q4
$3.31M Sell
488,217
-167,300
-26% -$1.13M ﹤0.01% 2686
2021
Q3
$3.48M Buy
655,517
+34,043
+5% +$180K ﹤0.01% 2679
2021
Q2
$3.57M Sell
621,474
-14,435
-2% -$83K ﹤0.01% 2655
2021
Q1
$2.93M Buy
635,909
+9,887
+2% +$45.6K ﹤0.01% 2702
2020
Q4
$2.09M Buy
626,022
+195,689
+45% +$654K ﹤0.01% 2815
2020
Q3
$1.28M Buy
430,333
+10,527
+3% +$31.3K ﹤0.01% 2968
2020
Q2
$1.94M Sell
419,806
-7,996
-2% -$36.9K ﹤0.01% 2702
2020
Q1
$1.65M Sell
427,802
-5,324
-1% -$20.5K ﹤0.01% 2644
2019
Q4
$1.62M Buy
433,126
+45,432
+12% +$170K ﹤0.01% 2948
2019
Q3
$2.06M Buy
387,694
+34,792
+10% +$185K ﹤0.01% 2747
2019
Q2
$1.36M Sell
352,902
-106,849
-23% -$410K ﹤0.01% 3029
2019
Q1
$2.34M Buy
459,751
+125,673
+38% +$641K ﹤0.01% 2699
2018
Q4
$641K Buy
334,078
+25,498
+8% +$48.9K ﹤0.01% 3348
2018
Q3
$1.17M Buy
308,580
+33,767
+12% +$128K ﹤0.01% 3173
2018
Q2
$858K Buy
274,813
+37,388
+16% +$117K ﹤0.01% 3330
2018
Q1
$568K Sell
237,425
-216,949
-48% -$519K ﹤0.01% 3522
2017
Q4
$1.78M Buy
454,374
+240,537
+112% +$941K ﹤0.01% 2902
2017
Q3
$539K Buy
213,837
+1,858
+0.9% +$4.68K ﹤0.01% 3555
2017
Q2
$585K Buy
211,979
+142,803
+206% +$394K ﹤0.01% 3533
2017
Q1
$135K Buy
69,176
+2,404
+4% +$4.69K ﹤0.01% 3961
2016
Q4
$70K Sell
66,772
-4,266
-6% -$4.47K ﹤0.01% 4080
2016
Q3
$77K Sell
71,038
-12,228
-15% -$13.3K ﹤0.01% 4080
2016
Q2
$59K Sell
83,266
-159,932
-66% -$113K ﹤0.01% 4146
2016
Q1
$285K Sell
243,198
-23,622
-9% -$27.7K ﹤0.01% 3661
2015
Q4
$654K Sell
266,820
-655
-0.2% -$1.61K ﹤0.01% 3399
2015
Q3
$803K Sell
267,475
-42,947
-14% -$129K ﹤0.01% 3298
2015
Q2
$1.28M Buy
310,422
+218,221
+237% +$901K ﹤0.01% 3198
2015
Q1
$399K Sell
92,201
-40
-0% -$173 ﹤0.01% 3695
2014
Q4
$274K Buy
92,241
+25,285
+38% +$75.1K ﹤0.01% 3804
2014
Q3
$222K Sell
66,956
-56,939
-46% -$189K ﹤0.01% 3861
2014
Q2
$313K Buy
123,895
+658
+0.5% +$1.66K ﹤0.01% 3731
2014
Q1
$279K Buy
123,237
+21,874
+22% +$49.5K ﹤0.01% 3747
2013
Q4
$198K Hold
101,363
﹤0.01% 3825
2013
Q3
$309K Buy
+101,363
New +$309K ﹤0.01% 3653